ML20133H558
| ML20133H558 | |
| Person / Time | |
|---|---|
| Issue date: | 12/30/1996 |
| From: | Rathbun D NRC OFFICE OF CONGRESSIONAL AFFAIRS (OCA) |
| To: | Faircloth L, Schaefer D HOUSE OF REP., SENATE, ENVIRONMENT & PUBLIC WORKS |
| Shared Package | |
| ML20133H561 | List: |
| References | |
| RULE-PRM-35-14 CCS, NUDOCS 9701170216 | |
| Download: ML20133H558 (2) | |
Text
cd
%4
- e UNITED STATES j
NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20565-0001 49.....,d December 30, 1996 The Honorable Lauch Faircloth, Chairman Subcommittee on Clean Air, Wetlands, Private Property and Nuclear Safety Committee on Environment and Public Works United States Senate Washington, DC 20510
Dear Mr. Chairman:
In the near future, the Nuclear Regulatory Commission (NRC) intends to publish in the Federal Reaister the enclosed notice of withdrawal of a Petition for Rulemaking (PRM-35-14), submitted by IsoStent, Inc. The petitioner requested that the NRC amend its regulations by adding a new section to address permanently implanted intraluminal stents, including phosphorus-32 and strontium-89 radioisotope stents. The petitioner also requested that the NRC add a new section to specify training and experience requirements for qualified physicians responsible for placing radioisotope stents in patients. The petitioner is withdrawing its petition for rulemaking based on public comments received by the NRC on the petition, and other information.
Sincerely, Dennis K. Rathbun, Director Office of Congressional Affairs
Enclosure:
Federal Register Notice cc: Senator Bob Graham i
9701170216 961230 PDR PRM 35-14 PDR.
t[* "CWg
',p w /,
k UNITED STATES f'tj NUCLEAR REGULATORY COMMISSION 3*
WASHsNGTON, D.C. 20555 4001 8
$^
December 30, 1996 The Honorable Dan Schaefer, Chairman l
Subcommittee on Energy and Power Committee on Commerce United States House of Representatives Washington, DC 20515
Dear Mr. Chairman:
In the near future, the Nuclear Regulatory Commission (NRC) intends to publish in the Federal Reaister the enclosed notice of withdrawal of a Petition for Rulemaking (PRM-35-14), submitted by isoStent, Inc. The petitioner requested that the NRC amend its regulations by adding a new section to address permanently implanted intraluminal stents, including phosphorus-32 and strontium-89 radioisotope stents. The petitioner also requested that the NRC add a new section to specify training and experience requirements for qualified physicians responsible for placing radioisotope l
stents in patients. The petitioner is withdrawing its petition for rulemaking based on public comments received by the NRC on the petition, and other information.
Sincerely,
/'
[
^
Dennis K. Rathbun, Director Office of Congressional Affairs
Enclosure:
Federal Register Notice cc: Representative Frank Pallone